Type 2 Diabetes Treatment Market
Global Type 2 Diabetes Treatment Market Size, Share & Trends Analysis Report, By Drug Class (Insulin, Non-Insulin (DPP-4 Inhibitor, GLP-1 Receptor, SGLT-2 Inhibitor)) By Devices (Insulin Pumps, Insulin Pen, Blood Glucose Meters, Others) Forecast Period 2022-2028 Update Available - Forecast 2024-2030
The global Type 2 Diabetes Treatment market is growing at a considerable CAGR of 6.6% during the forecast period (2022-2028). Type 2 diabetes accounts for around 90.0% of the total number of diabetes cases across the globe. The factors that contribute to the market growth are the rise in the level of obesity, lack of physical activity, and rise in the geriatric population. Moreover, family history of diabetes also plays a major role as according to the reports of the Centers for Diabetes Control and Preventions (CDC), one is likely to get diabetes if one’s family has one. People with prediabetes and gestational diabetes are more likely to get type 2 diabetes. In addition to this, consumption of an unhealthy diet and an increase in the prevalence of high blood pressure are some of the other factors that drive the growth of the type 2 diabetes treatment market.
However, inadequate funding and staff numbers in the undeveloped economy, high cost of the diagnosis and treatment, and complications with insulin for certain people are some of the constraints that are estimated to hamper the growth of the market in the forecast period. Conversely, government initiatives to control rising cases of diabetes and technological advancement are the opportunities estimated for the market players. For instance, in February 2020, AstraZeneca India launched Qtern® (Dapagliflozin 10mg + Saxagliptin 5mg film Coated Tablets) which is considered as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus (T2DM).
COVID-19 impact on the Type 2 Diabetes Treatment Market
The global type-2 diabetes treatment market is hardly hit by the outbreak of COVID-19 since December 2019. The outbreak of COVID-19 in these major economies has disrupted the manufacturing and supply of raw materials across the globe which resulted in a low supply of the products even due to a rise in diabetes cases because of lockdown. However, the market is estimated to grow in a forecast period as people with diabetes are at higher risk of getting COVID-19 infection.
Segmental Outlook
The market is segmented based on drug class and devices. Based on the drug class segment, the market is segmented into insulin and non-insulin. The insulin type segment held a considerable share in the drug class segment. When the blood sugar level is not normal people suffering from type 2 diabetes disease usually take insulin rather than other drugs According to the American Action Forum, around 8.3 million people require insulin to regulate blood glucose levels in the US. Around 22.0% of the US population was dependent on insulin for the control of diabetes. Moreover, it is estimated that the use of insulin will increase by 20.0% by 2030 across the globe. Further, based on the devices segment, the market is segmented into insulin pumps, insulin pens, blood glucose meters, and others.
Global Type 2 Diabetes Treatment Market Share by Drugs Class, 2021 (%)
Regional Outlooks
The global Type 2 Diabetes Treatment market is analyzed based on the geographical regions that are contributing significantly to the growth of the market. Based on the geography, the market is bifurcated into North America, Europe, Asia Pacific, and the Rest of the World. North America is estimated to have one of the major shares in the Type 2 Diabetes Treatment market. High prevalence of cancer diseases, investment in R&D in the US, regulatory approvals by FDA and CE for commercial use of these Type 2 Diabetes Treatment tests, and improved healthcare infrastructure are some of the factors that contribute to the growth of the market in this region. Asia-Pacific is estimated to be one of the fastest-growing regions in this market owing to the rise in awareness about the diagnosis and treatment for cancer diseases within the countries and government checks on the rising level of cancer patients.
Global Type 2 Diabetes Treatment Market Growth, by Region
Market Players Outlook
Key players of the type 2 diabetes treatment market are Merck & Co., Inc., Novo-Nordisk A/S, Eli Lilly and Co., Medtronic, PLC, AstraZeneca, PLC, Johnson, And Johnson Services, Inc.and GlaxoSmithKline, PLC. To survive in the market these players adopt different marketing strategies such as a merger, acquisitions, product launch, and geographical expansion so on. In August 2020, Medtronic PLC announced the acquisition of privately-held Companion Medical. The Medical company was a manufacturer of InPen which was the only insulin pen to date which got FDA approval. With this acquisition, Medtronic aims to expand the company’s ability to serve people where they are in their diabetes journey.
The Report Covers
- Market value data analysis of 2021 and forecast to 2028.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global type 2 diabetes treatment market based on the availability of data, information related to new product launches, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where in the market.
1.Report Summary
- Current Industry Analysis and Growth Potential Outlook
- Impact of COVID-19 on the Global Tissue Diagnostics Market
- Recovery Scenario of Global Tissue Diagnostics Market
1.1.Research Methods and Tools
1.2.Market Breakdown
1.2.1.By Segments
1.2.2.By Region
2.Market Overview and Insights
2.1.Scope of the Report
2.2.Analyst Insight & Current Market Trends
2.2.1.Key Findings
2.2.2.Recommendations
2.2.3.Conclusion
3.Competitive Landscape
3.1.Key Company Analysis
3.2.Key Strategy Analysis
3.3.Impact of Covid-19 on Key Players
4.Market Segmentation
4.1.Global Tissue Diagnostics Market by Technology
4.1.1.Immunohistochemistry
4.1.2.In-Situ Hybridization
4.1.3.H&E Stain
4.1.4.Special Staining
4.1.5.Digital Pathology
4.1.6.Others
4.2.Global Tissue Diagnostics Market by Diagnosis
4.2.1.Breast Cancer
4.2.2.Gastric Cancer
4.2.3.Lymphoma
4.2.4.Prostate Cancer
4.2.5.Non-Small Cell Lung Carcinoma
4.2.6.Others
4.3.Global Tissue Diagnostics Market by Product
4.3.1.Instrument
4.3.2.Consumables
4.4.Global Tissue Diagnostics Market by End-User
4.4.1.Hospitals & Clinics
4.4.2.Laboratories & Research Institutes
4.4.3.Others
5.Regional Analysis
5.1.North America
5.1.1.United States
5.1.2.Canada
5.2.Europe
5.2.1.UK
5.2.2.Germany
5.2.3.Italy
5.2.4.Spain
5.2.5.France
5.2.6.Rest of Europe
5.3.Asia-Pacific
5.3.1.China
5.3.2.India
5.3.3.Japan
5.3.4.South Korea
5.3.5.Rest of Asia-Pacific
5.4.Rest of the World
6.Company Profiles
6.1.Agilent Technologies
6.2.Allengers Medical Systems Ltd.
6.3.AliveCor Inc.
6.4.Becton, Dickinson & Company
6.5.Bio SB Inc.
6.6.Biocept
6.7.Bio-Genex Laboratories
6.8.bioMérieux SA
6.9.Caris Life Science
6.10.Cell Signalling Technology, Inc.
6.11.Danaher Corp.
6.12.Eurogentec
6.13.GE Healthcare
6.14.Grifols Diagnostic Solutions Inc.
6.15.F. Hoffmann-La Roche AG
6.16.Johnson & Johnson
6.17.Novodiax Inc.
6.18.Koninklijke Philips N.V.
6.19.Prometheus Laboratories
6.20.Quest Diagnostics
6.21.Siemens AG
6.22.Stryker Corp.
1.GLOBAL TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
2.GLOBAL TISSUE DIAGNOSTICS BY IMMUNOHISTOCHEMISTRY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3.GLOBAL TISSUE DIAGNOSTICS BY IN-SITU HYBRIDIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4.GLOBAL TISSUE DIAGNOSTICS BY H&E STAIN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
5.GLOBAL TISSUE DIAGNOSTICS BY SPECIAL STAIN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6.GLOBAL TISSUE DIAGNOSTICS BY DIGITAL PATHOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7.GLOBAL TISSUE DIAGNOSTICS BY OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
8.GLOBAL TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
9.GLOBAL TISSUE DIAGNOSTICS FOR BREAST CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
10.GLOBALTISSUE DIAGNOSTICS FOR GASTRIC CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
11.GLOBALTISSUE DIAGNOSTICS FOR LYMPHOMA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
12.GLOBALTISSUE DIAGNOSTICS FOR PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
13.GLOBALTISSUE DIAGNOSTICS FOR NON-SMALL CELL LUNGCARCINOMA MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
14.GLOBALTISSUE DIAGNOSTICS FOR OTHER MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
15.GLOBAL TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
16.GLOBALTISSUE DIAGNOSTICS BY INSTRUMENTS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
17.GLOBAL TISSUE DIAGNOSTICS BY CONSUMABLES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
18.GLOBAL TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
19.GLOBAL TISSUE DIAGNOSTICS FOR HOSPITALS & CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
20.GLOBAL TISSUE DIAGNOSTICS FOR LABORATORIES & RESEARCH INSTITUES MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
21.GLOBAL TISSUE DIAGNOSTICS FOR OTHER END-USERS MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
22.GLOBAL TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
23.NORTH AMERICAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
24.NORTH AMERICAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
25.NORTH AMERICAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
26.NORTH AMERICAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
27.NORTH AMERICAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
28.EUROPEAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
29.EUROPEAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
30.EUROPEAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
31.EUROPEAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
32.EUROPEAN TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
33.ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
34.ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
35.ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
36.ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2021-2028 ($ MILLION)
37.ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
38.REST OF THE WORLD TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2021-2028 ($ MILLION)
39.REST OF THE WORLD TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY DIAGNOSIS, 2021-2028 ($ MILLION)
40.REST OF THE WORLD TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY, 2021-2028 ($ MILLION)
41.REST OF THE WORLD TISSUE DIAGNOSTICS MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
1.IMPACT OF COVID-19 ON GLOBALTISSUE DIAGNOSTICS MARKET, 2021-2028 ($ MILLION)
2.IMPACT OF COVID-19 ON GLOBAL TISSUE DIAGNOSTICS MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3.RECOVERY OF GLOBAL TISSUE DIAGNOSTICS MARKET, 2022-2028 (%)
4.GLOBAL TISSUE DIAGNOSTICS MARKET SHARE BY TECHNOLOGY, 2021 VS 2028 (%)
5.GLOBAL TISSUE DIAGNOSTICS BY IMMUNOHISTOCHEMISTRY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6.GLOBAL TISSUE DIAGNOSTICS BY IN-SITU HYBRIDIZATION MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7.GLOBAL TISSUE DIAGNOSTICS BY H&E STAIN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
8.GLOBAL TISSUE DIAGNOSTICS BY SPECIAL STAINING MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9.GLOBAL TISSUE DIAGNOSTICS BY DIGITAL PATHOLOGY MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10.GLOBAL TISSUE DIAGNOSTICS BY OTHER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11.GLOBAL TISSUE DIAGNOSTICS MARKET SHARE BY DIAGNOSIS, 2021 VS 2028 (%)
12.GLOBAL TISSUE DIAGNOSTICS FOR BREAST CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
13.GLOBAL TISSUE DIAGNOSTICS FOR GASTRIC CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
14.GLOBAL TISSUE DIAGNOSTICS FOR LYMPHOMA MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
15.GLOBAL TISSUE DIAGNOSTICS FOR PROSTATE CANCER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
16.GLOBAL TISSUE DIAGNOSTICS FOR NON-SMALL CELL LUNG CARCINOMA MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
17.GLOBAL TISSUE DIAGNOSTICS FOR OTHER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
18.GLOBAL TISSUE DIAGNOSTICS MARKET SHARE BY PRODUCT, 2021 VS 2028 (%)
19.GLOBAL TISSUE DIAGNOSTICS BY INSTRUMENT MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
20.GLOBAL TISSUE DIAGNOSTICS BY CONSUMABLES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
21.GLOBAL TISSUE DIAGNOSTICS MARKET SHARE BY END-USER, 2021 VS 2028 (%)
22.GLOBAL TISSUE DIAGNOSTICS FOR HOSPITALS & CLINICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
23.GLOBALTISSUE DIAGNOSTICS FOR LABORATORIES & RESEARCH INSTITUES MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
24.GLOBALTISSUE DIAGNOSTICS FOR OTHERS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
25.GLOBAL TISSUE DIAGNOSTICS MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
26.US TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
27.CANADA TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
28.UKTISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
29.FRANCE TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
30.GERMANY TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
31.ITALY TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
32.SPAIN TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
33.REST OF EUROPE TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
34.INDIA TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
35.CHINA TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
36.JAPAN TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
37.SOUTH KOREA TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
38.REST OF ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, 2021-2028 ($ MILLION)
39.REST OF THE WORLD TISSUE DIAGNOSTICSMARKET SIZE, 2021-2028 ($ MILLION)
